Resources

This review aimed to undertake an assessment after 24 months listing on the LSDP to ensure that the listing of cerliponase alfa for the treatment of CLN2 disease remains appropriate. This review was considered by the Expert Panel at its October 2021 meeting.

Life Saving Drugs Program Expert Panel (LSDPEP) agenda for the 14th meeting on 17 February 2023.

These reports list the percentage of people who have been vaccinated against COVID-19 by local government area (LGA).

This presentation, delivered on 06 January 2023, contains an update to Australia's COVID-19 vaccine rollout.

This data file contains statistical data about Australia's COVID-19 vaccinations.

This weekly report provides a snapshot of data on the impact of COVID-19 in residential aged care facilities nationally. The report includes data on the number of services impacted and number of staff and resident cases, as well as workforce, testing and PPE provided to affected services.

Questions and Answers from Aged Care Funding Reforms Webinar #7, held on 17 November 2022

This report provides a summary of the organisation, engagement, evaluation and learnings that arose from the Health Technology Assessment (HTA) Consumer Consultative Committee (CCC) ‘Making Connections’ Symposium that was held in September 2021.

This fact sheet provides information about the COVIDSafe app data following its decommission.

This document contains the surveillance case definition for hepatitis C (individual aged less than 24 months), which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case.

Terms of reference for the Health Technology Assessment (HTA) Consumer Consultative Committee (CCC)

This document contains the surveillance case definition for chlamydial infection, which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case.

This document contains the surveillance case definition for gonococcal infection, which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case.

This document contains the surveillance case definition for hepatitis C (newly acquired), which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case.

This document contains the surveillance case definition for hepatitis C (unspecified), which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case.

This document contains the surveillance case definition for human immunodeficiency virus (HIV; child aged less than 18 months), which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case.

This document contains the surveillance case definition for human immunodeficiency virus (HIV; individual aged 18 months or older), which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case.

Advice by Australia's Chief Medical Officer, Professor Paul Kelly regarding the significant wave of COVID-19 infections currently being experienced in China.

This resource, in English, provides information about COVID testing for people travelling to Australia from the People’s Republic of China.

This report is of gifts given to officers of the Department of Health that are valued over $100, as at 31 December 2022.

This document outlines how we work with state and territory governments, the health and medicines industry, consumers and the media to ensure Australians have fair and affordable access to medicines.

This infographic issued on 23 December 2022 provides a weekly traffic light report of the coronavirus (COVID-19) situation across Australia.

This fact sheet, in Arabic, includes information about Japanese encephalitis virus (JEV).

A letter from the Chief Medical Officer to aged care providers about COVID-19 transmission and how to keep safe.